Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Q1 Earnings Risks Exposing Under Armour’s Irrelevance

Following a steep loss from the coronavirus pandemic, Under Armour stock is finally showing positive momentum. However, this may be a bull trap as the underlying business has grown increasingly irrelevant.

Can Q1 Earnings Help Twitter Lift Out of the Doldrums?

With millions forced to shelter at home, Twitter stock is a natural winner in terms of added viewership. But will this be enough to impress investors ahead of its Q1 earnings report?

9 Healthcare Stocks to Buy Even After the Coronavirus Fades

Several healthcare stocks have jumped higher based off the coronavirus pandemic. But these nine companies have a longer upside pathway.

The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors

The coronavirus has completely changed the narrative on AbbVie’s buyout of AGN. Allergan stock holders banking on it should reconsider.

Quarantine May Not Move Activision Blizzard Stock the Way You’d Expect

Call of Duty, the flagship franchise underlining Activision Blizzard stock, has declined in prominence as consumer behavior shifted toward non-violent games. But that might change because of the coronavirus.